Pharmaceuticals, Biotechnology and Life Sciences
The Science, Clinical Promise, & Market OutlookMELBOURNE, Australia, Jan. 15, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc”…
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market Preliminary, unaudited cash balance of approximately…
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no…
WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) — 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”),…
Company Shared Poster on Breakthrough Genetic Stratification Data from Positive Phase 2b OLIVE Trial Results for BH-200MUNICH, Germany, Jan. 15,…
SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) — ViroMissile, Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic…
STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster…
Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milk Norovirus-specific…
Regulated manufacturing, hospital field trials, and regulatory filings now underway with Ebulent Medical in ShenzhenLAS VEGAS, Jan. 15, 2026 (GLOBE…
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives…